1,709
Views
4
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma

, MD, , PhD, MPH, , PhD, , MD, PhD & , MD
Pages 187-193 | Received 08 Apr 2015, Accepted 03 Jul 2015, Published online: 15 Sep 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Michael J. Welch. (2016) Pharmacokinetics, pharmacodynamics, and clinical efficacy of albuterol RespiClick™ dry-powder inhaler in the treatment of asthma. Expert Opinion on Drug Metabolism & Toxicology 12:9, pages 1109-1119.
Read now

Articles from other publishers (3)

Lan‐Hong Ma, Li Jia & Ling Bai. (2023) Safety outcomes of salbutamol: A systematic review and meta‐analysis. The Clinical Respiratory Journal.
Crossref
Anna Volerman, Ashley A. Lowe, Andrea A. Pappalardo, Charmayne M. C. Anderson, Kathryn V. Blake, Tyra Bryant-Stephens, Thomas Carr, Heather Carter, Lisa Cicutto, Joe K. Gerald, Tina Miller, Nuala S. Moore, Hanna Phan, S. Christy Sadreameli, Andrea Tanner, Tonya A. Winders & Lynn B. Gerald. (2021) Ensuring Access to Albuterol in Schools: From Policy to Implementation. An Official ATS/AANMA/ALA/NASN Policy Statement. American Journal of Respiratory and Critical Care Medicine 204:5, pages 508-522.
Crossref
Joy Creaser-Thomas, Vignesh Rajasundaram & Gwyneth A Davies. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 161 171 .